Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Accuray Inc (ARAY) Insider Trading Activity
Healthcare • Medical Devices • 987 employees
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Total Value
-$707,064.88
Total Shares
-339,519
Average Trade Value
-$54,389.61
Most Active Insider
Winter Suzanne C
Total Activity: $287,238
Largest Single Transaction
$257,351
by Winter Suzanne C on Dec 2, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
SVP Chief Financial Officer
|
Dec 31, 2024 | 2,013 | $3,986 | 362,231 (-0.6%) | Payment of Exercise Price | |
President and CEO
|
Dec 2, 2024 | 119,698 | $257,351 | 1,216,778 (-9.8%) | Payment of Exercise Price | |
Chief Legal Officer
|
Dec 2, 2024 | 42,265 | $90,870 | 326,824 (-12.9%) | Payment of Exercise Price | |
SVP Chief Financial Officer
|
Dec 2, 2024 | 26,687 | $57,377 | 364,244 (-7.3%) | Payment of Exercise Price | |
Svp, Chief Commercial Officer
|
Dec 2, 2024 | 29,749 | $63,960 | 501,592 (-5.9%) | Payment of Exercise Price | |
Senior VP Global Operations
|
Dec 2, 2024 | 24,675 | $53,051 | 357,431 (-6.9%) | Payment of Exercise Price | |
Nov 9, 2024 | 22,642 | $44,831 | 187,362 (-12.1%) | Payment of Exercise Price | ||
Nov 9, 2024 | 22,642 | $44,831 | 119,333 (-19.0%) | Payment of Exercise Price | ||
SVP Chief Financial Officer
|
Oct 29, 2024 | 3,207 | $5,965 | 390,931 (-0.8%) | Payment of Exercise Price | |
Senior VP Global Operations
|
Sep 30, 2024 | 8,102 | $14,584 | 382,106 (-2.1%) | Payment of Exercise Price | |
Svp, General Counsel
|
Sep 30, 2024 | 12,831 | $23,096 | 369,089 (-3.5%) | Payment of Exercise Price | |
President
|
Sep 30, 2024 | 16,604 | $29,887 | 1,336,476 (-1.2%) | Payment of Exercise Price | |
SVP Chief Financial Officer
|
Sep 4, 2024 | 8,404 | $17,276 | 394,138 (-2.1%) | Sale |